United States · FDA National Drug Code directory
Cephalexin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-220_b0eb4846-bf8b-4322-b8c6-bfb2c252d5d4
- Product NDC
- 67877-220
- Form
- CAPSULE
- Composition / generic term
- Cephalexin
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110120
- Source listing expiry
- 20271231
Source-listed ingredients
- CEPHALEXIN — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (67877-220-01) · 67877-220-01
- 500 CAPSULE in 1 BOTTLE (67877-220-05) · 67877-220-05
- 1000 CAPSULE in 1 BOTTLE (67877-220-10) · 67877-220-10
- 20 CAPSULE in 1 BOTTLE (67877-220-20) · 67877-220-20
- 100 BLISTER PACK in 1 CARTON (67877-220-38) / 1 CAPSULE in 1 BLISTER PACK · 67877-220-38
- 50 BLISTER PACK in 1 CARTON (67877-220-74) / 1 CAPSULE in 1 BLISTER PACK · 67877-220-74
- 30 BLISTER PACK in 1 CARTON (67877-220-84) / 1 CAPSULE in 1 BLISTER PACK · 67877-220-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →